AFC
TECH icon

Ares Financial Consulting’s Bio-Techne TECH Stock Holding History

Ares Financial Consulting’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Sell
408
-60
-13% -$3.24K 0.02% 339
2026
Q1 		$25K Buy
468
+360
+333% +$21.6K 0.02% 345
2025
Q4 		$6.35K Buy
+108
New +$6.56K 0.01% 435

Other funds holding TECH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Ares Financial Consulting's TECH Position: Q2 2026 in Review

Ares Financial Consulting reduced its Bio-Techne (TECH) stake by 13% in Q2 2026, selling an estimated $3.24K and leaving 408 shares worth $28.8K. The position accounts for 0.02% of the portfolio, ranked #339.

Ares Financial Consulting first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. 234 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Ares Financial Consulting held 408 shares of Bio-Techne worth $28.8K as of Q2 2026.
  • Ares Financial Consulting sold 60 Bio-Techne shares in Q2 2026, an estimated $3.24K.
  • Bio-Techne made up 0.02% of Ares Financial Consulting's portfolio in Q2 2026, its #339 holding.
  • Ares Financial Consulting first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
  • 234 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.